Zobrazeno 1 - 10
of 21
pro vyhledávání: '"mesh:Neutropenia"'
Autor:
Fabrice Barlesi, Laure Deyme, Diane-Charlotte Imbs, Elissa Cousin, Mathieu Barbolosi, Sylvanie Bonnet, Pascale Tomasini, Laurent Greillier, Melissa Galloux, Albane Testot-Ferry, Annick Pelletier, Nicolas André, Joseph Ciccolini, Dominique Barbolosi
Publikováno v:
Cancer Chemotherapy and Pharmacology
Cancer Chemotherapy and Pharmacology, 2022, 90 (2), pp.149-160. ⟨10.1007/s00280-022-04455-x⟩
Cancer Chemotherapy and Pharmacology, 2022, 90 (2), pp.149-160. ⟨10.1007/s00280-022-04455-x⟩
A phase Ia/Ib trial of metronomic oral vinorelbine (MOV) driven by a mathematical model was performed in heavily pretreated metastatic Non-Small Cell Lung Cancer or Pleural Mesothelioma patients. Disease Control Rate, progression free survival, toxic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f34379e61159ac5c5cbc8be9e082bc3
https://inria.hal.science/hal-03923667
https://inria.hal.science/hal-03923667
Publikováno v:
Pharmacy Practice (Granada) v.17 n.3 2019
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Pharmacy Practice, Vol 17, Iss 3, p 1561 (2019)
Pharmacy Practice
Pharmacy Practice (Granada), Volume: 17, Issue: 3, Article number: 1561, Published: 25 NOV 2019
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Pharmacy Practice, Vol 17, Iss 3, p 1561 (2019)
Pharmacy Practice
Pharmacy Practice (Granada), Volume: 17, Issue: 3, Article number: 1561, Published: 25 NOV 2019
Background: Studies examining relationships between patient-related factors and treatment outcome in patients with candidemia are limited and often based on all-cause mortality. Objective: Our purpose was to examine the impact of concurrent renal rep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80d888abc999f04631d82e88061eaac0
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1885-642X2019000300015
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1885-642X2019000300015
Autor:
Robert G. Maki, Juhui James Jiao, Jean-Yves Blay, Jean-Louis Misset, A. Yovine, Antonio Nieto, Axel Le Cesne, Pilar Frontelo, Suzette Delaloge, George D. Demetri
Publikováno v:
Investigational New Drugs
Investigational New Drugs, Springer Verlag, 2012, 30 (3), pp.1193-202. ⟨10.1007/s10637-011-9662-0⟩
Investigational New Drugs, Springer Verlag, 2012, 30 (3), pp.1193-202. ⟨10.1007/s10637-011-9662-0⟩
International audience; PURPOSE: To summarize the safety experience obtained from phase II clinical trials conducted with trabectedin as single-agent therapy in patients with advanced solid tumors. METHODS: This retrospective analysis includes 1,132
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91cd37c1ac1159f13b68cdc74ff10cf8
https://doi.org/10.1007/s10637-011-9662-0
https://doi.org/10.1007/s10637-011-9662-0
Autor:
C. Montoto-Grillot, T. Conroy, E. Francois, J.P. Pignon, J-Y Pierga, E. Boucher, Bruno Chauffert, Antoine Adenis, Michel Ducreux, J.L. Ichante, M. Ychou
Publikováno v:
European Journal of Cancer
European Journal of Cancer, Elsevier, 2013, 49 (6), pp.1236-1245. ⟨10.1016/j.ejca.2012.12.011⟩
European Journal of Cancer, Elsevier, 2013, 49 (6), pp.1236-1245. 〈10.1016/j.ejca.2012.12.011〉
European Journal of Cancer, 2013, 49 (6), pp.1236-1245. ⟨10.1016/j.ejca.2012.12.011⟩
European Journal of Cancer, Elsevier, 2013, 49 (6), pp.1236-1245. ⟨10.1016/j.ejca.2012.12.011⟩
European Journal of Cancer, Elsevier, 2013, 49 (6), pp.1236-1245. 〈10.1016/j.ejca.2012.12.011〉
European Journal of Cancer, 2013, 49 (6), pp.1236-1245. ⟨10.1016/j.ejca.2012.12.011⟩
International audience; BACKGROUND:The combination of bevacizumab and bolus 5-fluorouracil, leucovorin and irinotecan is highly effective in patients with metastatic colorectal cancer (mCRC). This randomised, multicenter, non-comparative phase II tri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f92f6022d42644abefd6a8d3db5e8521
https://hal.univ-lorraine.fr/hal-01794473
https://hal.univ-lorraine.fr/hal-01794473
Publikováno v:
Critical Care
Critical Care, BioMed Central, 2010, 14 (3), pp.R98. 〈10.1186/cc9033〉
Critical Care, BioMed Central, 2010, 14 (3), pp.R98. ⟨10.1186/cc9033⟩
Critical Care, 2010, 14 (3), pp.R98. ⟨10.1186/cc9033⟩
Critical Care, BioMed Central, 2010, 14 (3), pp.R98. 〈10.1186/cc9033〉
Critical Care, BioMed Central, 2010, 14 (3), pp.R98. ⟨10.1186/cc9033⟩
Critical Care, 2010, 14 (3), pp.R98. ⟨10.1186/cc9033⟩
The AmarCand Study Group (ICU physicians): Drs. Allaouchiche (Lyon), Amigues (Montpellier), Ausseur (Saint Herblain), Azoulay (Paris), Badet (Lyon), Baldesi (Aix-en-Provence), Bastien (Bron), Baudin (Paris), Bayle (Lyon), Bazin (Clermont-Ferrand), Be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c21a3e7853f3fcbab9cac68182f3b32
http://www.hal.inserm.fr/inserm-00663894/document
http://www.hal.inserm.fr/inserm-00663894/document
Autor:
Thorsten Braun, Grégory Jouvion, Olivier Lortholary, Jean-Michel Correas, Sophie Candon, C. Maunoury, Blandine Rammaert, Marie-Elisabeth Bougnoux
Publikováno v:
Transplant Infectious Disease
Transplant Infectious Disease, Wiley, 2017, 19 (1), pp.e12637. ⟨10.1111/tid.12637⟩
Transplant Infectious Disease, 2017, 19 (1), pp.e12637. ⟨10.1111/tid.12637⟩
Transplant Infectious Disease, Wiley, 2017, 19 (1), pp.e12637. ⟨10.1111/tid.12637⟩
Transplant Infectious Disease, 2017, 19 (1), pp.e12637. ⟨10.1111/tid.12637⟩
International audience; Chronic disseminated candidiasis (CDC) is a rare and difficult‐to‐treat invasive fungal disease occurring mainly after prolonged and profound neutropenia. We describe the case of a 59‐year‐old man successfully treated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b7e8bdd9f0b65606d4ddd6ba9d08a74
https://doi.org/10.1111/tid.12637
https://doi.org/10.1111/tid.12637
Publikováno v:
Journal of Clinical Oncology
Journal of Clinical Oncology, American Society of Clinical Oncology, 1998, 16 (8), pp.2700-7
HAL
Journal of Clinical Oncology, 1998, 16 (8), pp.2700-7
Journal of Clinical Oncology, American Society of Clinical Oncology, 1998, 16 (8), pp.2700-7
HAL
Journal of Clinical Oncology, 1998, 16 (8), pp.2700-7
PURPOSE The clinical indications and economic consequences of human granulocyte colony-stimulating factor (G-CSF) prescription during small-cell lung cancer (SCLC) chemotherapy remain controversial. The aim of this study, based on a Markov model, was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f33dfed4d276cf8c333ef9445bae4f88
https://doi.org/10.1200/jco.1998.16.8.2700
https://doi.org/10.1200/jco.1998.16.8.2700
Autor:
Arij Mechergui, Wafa Achour, Assia Ben Hassen, Dario Giorgini, Muhamed-Kheir Taha, Rekaya Baaboura
Publikováno v:
APMIS
APMIS, Wiley, 2013, 121 (9), pp.843-847. ⟨10.1111/apm.12042⟩
APMIS, 2013, 121 (9), pp.843-847. ⟨10.1111/apm.12042⟩
APMIS, Wiley, 2013, 121 (9), pp.843-847. ⟨10.1111/apm.12042⟩
APMIS, 2013, 121 (9), pp.843-847. ⟨10.1111/apm.12042⟩
International audience; Multilocus sequence typing and pulsed-field gel electrophoresis were used to type 22 commensal isolates of Neisseria perflava collected by swabbing from neutropenic patients. High genetic diversity was found among our N. perfl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2dfb7a367fbeb6c124b10149cce71811
https://hal-pasteur.archives-ouvertes.fr/pasteur-02089345
https://hal-pasteur.archives-ouvertes.fr/pasteur-02089345
Autor:
Ordoñez-Rueda, Diana, Jönsson, Friederike, Mancardi, David, Zhao, Weidong, Malzac, Aurélie, Liang, Yinming, Bertosio, Elodie, Grenot, Pierre, Blanquet, Véronique, Sabrautzki, Sybille, de Angelis, Martin Hrabě, Méresse, Stéphane, Duprez, Estelle, Bruhns, Pierre, Malissen, Bernard, Malissen, Marie
Publikováno v:
European Journal of Immunology
European Journal of Immunology, Wiley-VCH Verlag, 2012, 42 (9), pp.2395-2408. ⟨10.1002/eji.201242589⟩
Eur. J. Immunol. 42, 2395-2408 (2012)
European Journal of Immunology, 2012, 42 (9), pp.2395-2408. ⟨10.1002/eji.201242589⟩
European Journal of Immunology, Wiley-VCH Verlag, 2012, 42 (9), pp.2395-2408. ⟨10.1002/eji.201242589⟩
Eur. J. Immunol. 42, 2395-2408 (2012)
European Journal of Immunology, 2012, 42 (9), pp.2395-2408. ⟨10.1002/eji.201242589⟩
International audience; Using N-ethyl-N-nitrosourea-induced mutagenesis, we established a mouse model with a novel form of neutropenia resulting from a point mutation in the transcriptional repressor Growth Factor Independence 1 (Gfi1). These mice, c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::b9f8cd927afbeb89c00d563bcaa20eb4
https://hal-pasteur.archives-ouvertes.fr/pasteur-02518924
https://hal-pasteur.archives-ouvertes.fr/pasteur-02518924
Autor:
Frébet, Elise, Abraham, Julie, Geneviève, Franck, Lepelley, Pascale, Daliphard, Sylvie, Bardet, Valérie, Amsellem, Sophie, Guy, Julien, Mullier, Francois, Durrieu, Francoise, Venon, Marie-Dominique, Leleu, Xavier, Jaccard, Arnaud, Faucher, Jean-Luc, Béné, Marie C, Feuillard, Jean, Renseigné, Non
Publikováno v:
Cytometry Part B Clinical Cytometry
Cytometry Part B Clinical Cytometry, 2010, 363 (26), epub ahead of print. ⟨10.1002/cyto.b.20581⟩
Cytometry Part B: Clinical Cytometry
Cytometry Part B: Clinical Cytometry, Wiley, 2011, 80 (3), pp.176-85. ⟨10.1002/cyto.b.20581⟩
Cytometry Part B Clinical Cytometry, 2010, 363 (26), epub ahead of print. ⟨10.1002/cyto.b.20581⟩
Cytometry Part B: Clinical Cytometry
Cytometry Part B: Clinical Cytometry, Wiley, 2011, 80 (3), pp.176-85. ⟨10.1002/cyto.b.20581⟩
International audience; BACKGROUND:: Flow cytometry is the sole available technique for quantification of tumor plasma-cells in plasma-cell disorders, but so far, no consensus technique has been proposed. Here, we report on a standardized, simple, ro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7361e9d3a693ce2d228c45674af1f66d
https://hal.archives-ouvertes.fr/hal-00559641
https://hal.archives-ouvertes.fr/hal-00559641